BioTime’s (Amex: BTX) OncoCyte provides future alternative Blood Test to detect Breast and Colorectal Cancers
March 23rd, 2012
No comments
An annual PanC-Dx^TM blood test could be the future alternative to the mammogram Read more…
Categories: BioTime (AMEX:BTX), OncoCyte Corporation
